Abstract
BackgroundThe current therapeutic antibodies and chimeric antigen receptor (CAR) T cells are capable of recognizing surface antigens, but not of intracellular proteins, thus limiting the target coverage for drug development....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have